+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acorda Therapeutics Inc - logo

Acorda Therapeutics is a biopharmaceutical company that identifies, develops, and commercializes novel therapies for neurological disorders in the United States. It specializes in drugs that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Its best known products are Zanaflex, Ampyra and Qutenza. Acorda Therapeutics was founded in 1995 and is headquartered in Ardsley, New York.

Muscle Relaxant Drugs Market - Growth, Trends and Forecasts (2023-2028) - Product Thumbnail Image

Muscle Relaxant Drugs Market - Growth, Trends and Forecasts (2023-2028)

  • Report
  • April 2023
  • 114 Pages
  • Global
From
Global Cerebral Palsy Market 2021-2025 - Product Thumbnail Image

Global Cerebral Palsy Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
Pharma and ESG - The Patient Perspective - The Views of 1,500 Patient Groups - Product Thumbnail Image

Pharma and ESG - The Patient Perspective - The Views of 1,500 Patient Groups

  • Report
  • June 2022
  • 63 Pages
  • Global
Non-Opioid Analgesic Patch Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Non-Opioid Analgesic Patch Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 128 Pages
  • Global
From
Spinocerebellar Ataxia (SCA) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Spinocerebellar Ataxia (SCA) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • October 2023
  • 78 Pages
  • Global
From
Herpes Zoster (Shingles) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Herpes Zoster (Shingles) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • January 2023
  • 236 Pages
  • Global
From
Inhalers - Medical Devices Pipeline Assessment, 2019 - Product Thumbnail Image

Inhalers - Medical Devices Pipeline Assessment, 2019

  • Report
  • May 2019
  • 357 Pages
  • Global
From
VAP-1 Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

VAP-1 Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
Primary Sclerosing Cholangitis Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Primary Sclerosing Cholangitis Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • August 2020
  • 98 Pages
  • Global
From
Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • May 2020
  • 178 Pages
  • Global
From
Acorda Therapeutics Inc (ACOR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Acorda Therapeutics Inc (ACOR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 89 Pages
From
Acorda Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Acorda Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • April 2024
  • 50 Pages
From
Comprehensive Report on Acorda Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Acorda Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • August 2023
  • 55 Pages
From
Acorda Therapeutics, Inc. - Company Profile and SWOT Analysis - Product Thumbnail Image

Acorda Therapeutics, Inc. - Company Profile and SWOT Analysis

  • SWOT Analysis
  • January 2024
  • 43 Pages
From
Loading Indicator